C25H31N5O9S
Neat
577184
1706671-50-2; 9G4A3UXP7T; (2R)-N-((4-Ethyl-2, 3-dioxo-1-piperazinyl)carbonyl)-2-((2R)-phenylglycyl)-2-((2R, 4S)-3-acetyl-4-carboxy-5, 5-dimethyl-2-thiazolidinyl)glycine; Glycine, (2R)-N-((4-ethyl-2, 3-dioxo-1-piperazinyl)carbonyl)-2-phenylglycyl-2-((2R, 4S)-3-acetyl-4-carboxy-5, 5-dimethyl-2-thiazolidinyl)-, (2R)-; UNII-9G4A3UXP7T; Piperacillin sodium impurity F [EP]; PIPERACILLIN SODIUM IMPURITY F [EP IMPURITY]; (2R, 4S)-3-acetyl-2-((R)-carboxy((R)-2-(4-ethyl-2, 3-dioxopiperazine-1-carboxamido)-2-phenylacetamido)methyl)-5 and 5-dimethylthiazolidine-4-carboxylic acid
(2R, 4S)-3-acetyl-2-[(R)-carboxy-[[(2R)-2-[(4-ethyl-2, 3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]methyl]-5, 5-dimethyl-1 and 3-thiazolidine-4-carboxylic acid
InChI=1S/C25H31N5O9S/c1-5-28-11-12-29(20(34)19(28)33)24(39)27-15(14-9-7-6-8-10-14)18(32)26-16(22(35)36)21-30(13(2)31)17(23(37)38)25(3,4)40-21/h6-10,15-17,21H,5,11-12H2,1-4H3,(H,26,32)(H,27,39)(H,35,36)(H,37,38)/t15-,16+,17+,21-/m1/s1